Show simple item record

dc.contributor.authorOffice of Marketing and Communications. Media Relations
dc.date.accessioned2017-07-11T17:38:12Z
dc.date.available2017-07-11T17:38:12Z
dc.date.issued2017-06-27
dc.identifier.urihttps://hdl.handle.net/1813/52037
dc.description.abstractThe news item from the Cornell Chronicle is about: Dr. Brian VanderVen, assistant professor of microbiology and immunology, and colleagues at Cornell’s College of Veterinary Medicine, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis. The finding is published in the journal eLife.
dc.language.isoen_US
dc.publisherCornell University, College of Veterinary Medicine
dc.subjectCornell University. College of Veterinary Medicine -- Periodicals.
dc.subjectVanderVen, Brian
dc.subjectRoberts, Lauren Cahoon
dc.subjectCornell Chronicle
dc.title2017 CVM News: Dr. Brian VanderVen's paper pinpoints a new target for tuberculosis drugs
dc.title.alternativeNew discovery holds potential as tuberculosis drug
dc.typearticle


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics